Skip to content

Implementing community-engaged pharmacogenomics in Indigenous communities

Dr Casey Dorr

Casey Dorr, PhD, is a nephrology investigator at Hennepin Healthcare Research Institute (HHRI) and first-generation descendant of the Mille Lacs Band of Ojibwe. He’s passionate about using innovative research in pharmacogenomics (PGx), the efficacy of medication based on genetic variations; to create inclusive precision medicine for Indigenous communities to reduce health disparities and improve health outcomes.

It is this very research that has led to a recent collaborative publication with Dr. Katrina Claw at the University of Colorado and Dr. Erica Woodahl at the University of Montana in the prestigious Nature Communications on “Implementing community-engaged pharmacogenomics in Indigenous communities.” From start to finish, this peer review process took over two years to complete.

In this publication, Dr. Dorr advocates for increased indigenous participation in medical research and to center the research around the culture, traditions, and values of indigenous communities. Thus, yielding more individualized results for precision medicine to heal health disparities in indigenous communities. You can read the article in its entirety here.

input search string and hit enter